TS-142: Clinical Trials

15 trials of TS-142, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed. 11 Phase 1, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 111Completed 11
Phase 22Completed 2
Phase 32Completed 2

Follow TS-142: new trials by email Literature Review of TS-142 trials Research Report on TS-142

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects
TS-142, Zopiclone, Placebo - Healthy Subjects
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.432023-05-152025-02-28
A Food Effect Study of TS-142 in Healthy Subjects
TS-142 10 mg - Effect of Food
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.122023-02-152025-02-28
A Pharmacokinetic Study of TS-142 in Patients with Hepatic Impairment
TS-142 5 mg - Patients with Mild or Moderate Hepatic Impairment
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.842022-12-262025-02-28
Long-Term Study of TS-142 in Patients with Insomnia
TS-142 5 mg, TS-142 10 mg - Patients with Insomnia
Phase 3CompletedTaisho Pharmaceutical Co., Ltd.4012022-10-112025-02-28
Phase III Study of TS-142 in Patients with Insomnia
TS-142 5 mg, TS-142 10 mg, Placebo to TS-142 - Patients with Insomnia
Phase 3CompletedTaisho Pharmaceutical Co., Ltd.11552022-08-302025-02-28
A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects
TS-142, Moxifloxacin, Placebo - Healthy Subjects
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.592021-06-072025-02-28
Mass Balance Study of TS-142 in Healthy Adult Subjects.
[14C] TS-142 - Healthy Male Subjects
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.62021-04-192025-02-28
A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.
TS-142, Dose-matched Placebo to TS-142 - Patients with Mild Obstructive Sleep Apnea Hypopnea
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.462021-02-242025-02-28
A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects
TS-142, Zopiclone, Placebo - Healthy Subjects
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.612021-01-162025-02-28
Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole)
TS-142, Itraconazole - Healthy Subjects
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.102020-10-132025-02-28
A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy Participants
TS-142, TS-142 Placebo - Healthy Volunteers
Phase 1CompletedTaisho Pharmaceutical R&D Inc.282020-09-142021-02-10
Late Phase II Study of TS-142 in Patients with Insomnia
TS-142 - Patients with Insomnia
Phase 2CompletedTaisho Pharmaceutical Co., Ltd.1792020-09-092025-02-28
Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder
TS-142, Dose-matched Placebo to TS-142 - Insomnia Disorder
Phase 2CompletedTaisho Pharmaceutical Co., Ltd.242017-07-072025-02-28
A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)
Placebo, TS-142, 10 mg, TS-142, 20 mg - Healthy Volunteer
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.242016-07-062025-02-28
A Phase I Study of TS-142 in Healthy Participants (Single Doses)
Placebo (fasting), Placebo (feeding), 1 mg of TS-142 - Healthy Volunteer
Phase 1CompletedTaisho Pharmaceutical Co., Ltd.322015-10-172025-02-28

Conditions studied

Sleep Initiation and Maintenance Disorders (1)

Sponsors

Taisho Pharmaceutical Co., Ltd. (14)  ·  Taisho Pharmaceutical R&D Inc. (1)

Countries

Japan (14)  ·  United States (1)

Top investigators

Taisho Direcoter (3)  ·  Shigeru Okuyama (2)  ·  Toshiro Heya (1)

Results publications

PMID 37563858, PMID 35296912, PMID 41001841, PMID 42174196